Much of the growth is expected from minimally invasive spine fusion, but the smaller facet fixation segment will also increase in revenue, according to the report.
Several minimally invasive spine fusion clinical trial outcomes may impact the market, as favorable results will likely boost the number of procedures done with minimally invasive technology.
Challenges still remain to the segment’s growth, though. Physicians require extensive additional training to implement minimally invasive procedures, and reimbursements will remain low until more efficacy has been proven.
More Articles on Devices:
Study: Bioactive Film Coating Could Improve Spine Device Success
OsteoFab Orthopedic Device Receives FDA Clearance
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.